SCHEMBL23866583

SCHEMBL23866583

CC(C)C(=O)NC[C@H]1CCCN1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.48
PREP P48147 1/20 0.48
FAP Q12884 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 1/20 0.41
OPRM1 P35372 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
MALT1 Q9UDY8 1/20 0.37
KAT2B Q92831 1/20 0.37
DRD2 P14416 1/20 0.37
DRD1 P21728 1/20 0.37
DRD4 P21917 1/20 0.37
DRD5 P21918 1/20 0.37
DRD3 P35462 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12413667 1.00 DPP4 (0.48) DPP4PREPFAPL3MBTL1HTT
SCHEMBL13115966 0.95 DPP4 (0.43) DPP4PREPFAPL3MBTL1HTT
SCHEMBL12155765 0.84 DPP4 (0.46) DPP4PREPFAPL3MBTL1ALDH1A1
SCHEMBL11240147 0.82 OPRM1 (0.46) L3MBTL1HTTALDH1A1OPRM1CHRNB2
SCHEMBL12506716 0.81 FAP (0.44) DPP4PREPFAPL3MBTL1ALDH1A1
SCHEMBL8320704 0.81 FAP (0.44) DPP4PREPFAPL3MBTL1ALDH1A1
SCHEMBL29358366 0.81 CHRNB2 (0.44) L3MBTL1ALDH1A1OPRM1CHRNB2CHRNA5
SCHEMBL14020493 0.81 L3MBTL1 (0.69) L3MBTL1HTTMEN1KMT2AALDH1A1
SCHEMBL18421385 0.78 MEN1 (0.43) DPP4MEN1KMT2A
SCHEMBL21661030 0.78 MTNR1A (0.46) L3MBTL1HTTALDH1A1CHRNB2CHRNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300940-A1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300940-A1 TLR7/8 ANTAGONISTS AND USES THEREOF TLR7, TLR8, TLR9 DPP4 1190/4885PREP 3456/4885FAP 2314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.